CM Plus International Limited
CM Plus International Limited is a Singapore-headquartered GMP/GDP consulting and engineering services firm serving pharmaceutical, medical device, food, cosmetics, and data center clients across Japan and Southeast Asia, operating a proprietary GMP training platform and an AI-augmented regulatory advisory product (pharmo.AI).
- Company typePrivate
- Founded2013
- HeadquartersYokohama, Japan
- Headcount—
- GTM typeB2B
- OfferingServices
What CM Plus International Limited does
CM Plus International Limited is a Singapore-headquartered consulting and engineering services firm specializing in regulated industries across Southeast Asia and Japan. Founded in 2013 with initial operations in Vietnam and later expanded via a 2014 Singapore headquarters, a 2015 Indonesia subsidiary, and a Japanese operating subsidiary (CM Plus Corporation / 株式会社シーエムプラス), the firm delivers GMP/GDP consulting, engineering and project management, technical education and training, and technical information services. Its principal client base spans pharmaceutical manufacturers, medical device companies, food and cosmetics producers, and adjacent regulated-tech operators such as data center and audio equipment firms. Named enterprise clients include Takeda, Chugai, Terumo, AlphaTheta, IIJ, Takasago, Medreich, Tsamura, Acecook, and Milliona Cosmetics, indicating an enterprise-only go-to-market with no SMB exposure.
The company operates proprietary digital assets, most notably a GMP Platform with more than 26,000 registered users, and in October 2025 launched pharmo.AI, an AI-augmented pharmaceutical regulatory and compliance advisory service that pairs an AI agent with human consultants. Its business model is professional services-led, generating revenue from multi-month engineering and regulatory project engagements, training subscriptions tied to the GMP Platform, technical information services, and emerging SaaS-like AI advisory offerings. Geographic revenue exposure spans Japan, Singapore, Vietnam, and Indonesia, with active partnership channels extending into India (Medhini Group / JS-SEZ), Malaysia-aligned halal markets (Halal Japan Association), and broader ASEAN.
CM Plus International Limited firmographics
Firmographics- Name
- CM Plus International Limited
- Legal name
- 株式会社シーエムプラス (CM Plus Corporation)
- Website
- https://cm-plus.co.jp
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Short description
- CM Plus International Limited is a Singapore-headquartered GMP/GDP consulting and engineering services firm serving pharmaceutical, medical device, food, cosmetics, and data center clients across Japan and Southeast Asia, operating a proprietary GMP training platform and an AI-augmented regulatory advisory product (pharmo.AI).
- Ownership category
- akta.pro rank
CM Plus International Limited industry classification
Industry- Product category
- Pharmaceutical Engineering & GMP Consulting Services
- NAICS
- Computer Systems Design and Related Services (54151)
- akta.pro primary industry
- GMP Manufacturing Support Services (QA/QMS, validation, documentation) (HLAAAKAH)
- akta.pro secondary industries
- CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC) (HLAGAKAB), Construction Management & Delivery (EPCM/CMAR/Design-Build Oversight) (EUANALAE)
Keywords
Where CM Plus International Limited is headquartered
LocationHeadquarters
- HQ city
- Yokohama
- HQ country
- Japan
- HQ region
- Asia
Offices4 records
Markets served
CM Plus International Limited business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Engineering and Project Management Services: Construction management, project management consulting, and PMC services for production facility construction projects, particularly for pharmaceutical, medical device, food, cosmetics, and other manufacturing facilities.
- GMP/GDP and Regulatory Consulting: Quality management consulting including GMP compliance, validation, data integrity, contamination control strategy, and pharmaceutical regulatory affairs services.
- Education and Training Services: Open seminars, e-learning programs, and on-site training for GMP auditors and life sciences professionals.
- Technical Information Services: Information platform services including GMP Platform, iVEXL exhibitions, and CORRESSA project collaboration tools.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
CM Plus International Limited product offering
Product offeringCore offering
CM Plus International provides one-stop engineering, consulting, and training services for life sciences and manufacturing facility construction. The company delivers construction management (CM) and project management consultant (PMC) services for pharmaceutical, medical device, food, cosmetics, semiconductor, and data center facility projects, alongside GMDP (GMP & GDP) consulting, validation, regulatory affairs, and education/training support. Proprietary information platforms (GMP Platform, iVEXL, CORRESSA, pharmo.AI, CMP Way) extend the offering with digital knowledge, collaboration, and AI-assisted regulatory support.
Product overview
CM Plus International Limited provides a comprehensive suite of life sciences manufacturing support services organized into four core pillars: Engineering & Project Management (production facility construction, CM/PMC services), Consulting (GMDP, QMS, regulatory affairs, validation), Education/Training, and Technical Information Services. The technical information services encompass multiple branded platforms including GMP Platform (regulatory knowledge portal), iVEXL (digital exhibition platform), CORRESSA (project collaboration tool), and CMP Way (energy management). The company recently launched pharmo.AI, an AI-powered GMP consulting service combining autonomous AI agents with human consultants for pharmaceutical regulatory affairs support. Services span pharmaceuticals, medical devices, food, cosmetics, semiconductors, data centers, chemical plants, and logistics sectors across Asia (Japan, Singapore, Vietnam, Indonesia) and globally.
Differentiator
Problem solved
Functional benefit
Brands
- pharmo.AI: AI agent and consultant hybrid type GMP consulting service for pharmaceutical regulatory research and drug business support.
- iVEXL
- GMP Platform
- CORRESSA
- CMP Way
Products and services
- Engineering & Project Management Services
- Consulting Services
- Education/Training Support
- pharmo.AI
- CORRESSA
- GMP Platform
- iVEXL
- CMP Way Energy Management
- Overseas Factory Construction Information Platform
Quantifiable outcome
- 26,000+ registered users on GMP Platform
- +1 more outcomes
Companies that use CM Plus International Limited
Customer profileNamed customers10 records
Segments6 records
Ideal customer profiles1 record
CM Plus International Limited technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature7 records
CM Plus International Limited partnerships and signals
Strategic signalPartnerships
20 partnerships are on record, tiered core and minor.
- Memsift Innovations (Singapore)coreStrategic partnership for Singapore-based operations, supporting membrane technology solutions for pharmaceutical and industrial applications in the Southeast Asian market.
- Meta Tech AP Co., Ltd. (Taiwan)minorPartnership for bio, regenerative medicine, cell therapy, gene therapy, and AI/DX business promotion.
- Locus Cell Co., Ltd. (Taiwan)minorPartnership for bio, regenerative medicine, cell therapy, gene therapy, and AI/DX business promotion.
- Vietnam Institute of Building Science and Technology (IBST)coreMOU for strategic partnership to provide one-stop, rapid, and reliable support for Vietnamese local regulations compliance and global quality standards assurance.
- Halal Japan AssociationcorePartnership to support halal business operations, providing guidance and consulting for Japanese companies entering halal markets.
- Fukuda & PartnersminorPartnership for logistics facility construction in overseas markets, providing Japanese-quality engineering services.
- Medhini Group Sdn Bhd (Malaysia)minorPartnership for Johor-Singapore Special Economic Zone (JS-SEZ) entry support, providing market access and consulting services.
- HIS Toyyiba Sdn. Bhd. (Malaysia)corePartnership for halal certification support services including factory construction consulting, certification acquisition, and education training in Japan. HIS Toyyiba is under Selangor State Government MBI.
- Medhini Group Sdn BhdminorChannel partner for Malaysia market covering Selangor region
- Veritas Design Group (Malaysia)minorDesign and architecture services partner in Malaysia
- TLC Architect (Malaysia)minorArchitecture services partner in Malaysia
- IPS-Mehtalia Pvt. Ltd. (India)minorEngineering and design services partner in India
- Jonathan O. Gan & Associates (Philippines)minorArchitecture services partner in Philippines
- GF & Partners Architects (Philippines)minorArchitecture services partner in Philippines
- SASI D&M Co., Ltd. (Thailand)minorEngineering and design services partner in Thailand
- EEC Engineering (Thailand)minorEngineering services partner in Thailand
- ON GROUND (Thailand)minorEngineering services partner in Thailand
- CRB Group, Inc. (USA)minorEngineering and construction services partner in United States
- Arcadis (Netherlands)minorEngineering and design services partner in Europe
- TANDEM (Ireland)minorProject management services partner in Ireland
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
CM Plus International Limited competitors and assessment
Company assessmentDirect peers
- NNE: Denmark-rooted engineering and consulting firm specialized in pharma manufacturing facilities, with deep GMP and process design expertise. Direct competitor for international pharma facility construction projects where CM Plus bids.
- PM Group: Ireland-based international project delivery firm specializing in pharma, food, and medtech facility construction and consulting. Directly comparable in service mix and mid-sized specialized positioning; listed as a TANDEM-style partner in CM Plus's network.
- CRB Group: US-headquartered engineering, architecture, and consulting firm focused on life sciences facilities (pharma, biotech, medical devices). Directly comparable to CM Plus's engineering + GMP/QA consulting model; CRB is also listed as an explicit collaboration partner of CM Plus for cross-border project support.
- Exyte: German-headquartered global EPCM firm specializing in high-tech facilities including pharma, biotech, and semiconductor cleanrooms. Comparable to CM Plus's construction management work in semiconductors and life sciences; operates at significantly larger scale.
- IPS (Integrated Project Services): US-based EPCM and consulting firm exclusively serving regulated life sciences industries, including facility construction, validation, and GMP compliance. Highly comparable to CM Plus across all four service pillars.
Broad incumbents
- Stantec: Global engineering, architecture, and environmental services firm with a Life Sciences practice covering pharma, food, and cosmetics facility consulting. Overlaps with CM Plus's broader industry coverage (food, cosmetics, industrial facilities).
- WSP Global: Global professional services and engineering consultancy with a Property & Buildings practice serving pharma, healthcare, and industrial clients. Comparable at the broad EPCM and facility consulting layer, though much larger and more diversified.
- Arcadis: Global design and consultancy firm with significant life sciences and industrial facilities practice. Listed as an explicit European collaboration partner of CM Plus for cross-border projects, and a broad incumbent in the same end-markets.
- Jacobs Solutions: Large global professional services and EPCM firm with a life sciences and advanced facilities practice. Competes with CM Plus on large pharma capex projects, though Jacobs is much broader in scope and scale.
Regional players
- Chiyoda Corporation: Major Japanese engineering and construction firm with pharma/life sciences capability and ASEAN project experience. Most directly comparable Japanese-headquartered peer; larger scale but broader industrial focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
CM Plus International Limited social profiles
Digital presenceCM Plus International Limited financial estimates
Financial estimateRevenue estimate
Valuation estimate
CM Plus International Limited leadership team
Management profileNumber of profiles
Profiles7 records
CM Plus International Limited subsidiaries and ownership
Company hierarchySubsidiaries3 records
CM Plus International Limited funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CM Plus International Limited M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CM Plus International Limited
What does CM Plus International Limited do?
CM Plus International provides one-stop engineering, consulting, and training services for life sciences and manufacturing facility construction. The company delivers construction management (CM) and project management consultant (PMC) services for pharmaceutical, medical device, food, cosmetics, semiconductor, and data center facility projects, alongside GMDP (GMP & GDP) consulting, validation, regulatory affairs, and education/training support. Proprietary information platforms (GMP Platform, iVEXL, CORRESSA, pharmo.AI, CMP Way) extend the offering with digital knowledge, collaboration, and AI-assisted regulatory support.
Is CM Plus International Limited a public or private company?
CM Plus International Limited is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CM Plus International Limited founded?
CM Plus International Limited was founded in 2013.
Where is CM Plus International Limited based?
CM Plus International Limited is headquartered in Yokohama, Japan, in the Asia region.
How does CM Plus International Limited make money?
Four revenue lines are on record. Engineering and Project Management Services are the primary driver. The others are GMP/GDP and Regulatory Consulting, education and Training Services and technical Information Services.
Who are CM Plus International Limited's main competitors?
Direct peers on record are NNE, PM Group, CRB Group, Exyte and IPS (Integrated Project Services). Broad incumbents are Stantec, WSP Global, Arcadis and Jacobs Solutions. Chiyoda Corporation is listed as a regional player.
Does CM Plus International Limited have an API?
No public API is recorded for CM Plus International Limited.
What industry is CM Plus International Limited in?
CM Plus International Limited's product category is Pharmaceutical Engineering & GMP Consulting Services. Its primary akta.pro industry code is HLAAAKAH, GMP Manufacturing Support Services (QA/QMS, validation, documentation), with a secondary code of HLAGAKAB, CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC). Its NAICS code is 54151.